Intuitive Surgical, Inc. (ISRG, Financial) sells the 'da Vinci' robotic surgical system. The company's recent results fell short of expectations because of a slowdown in domestic benign gynecological procedures using da Vinci devices. This, in turn, led to slower than expected overall procedure growth and systems sales; management lowered its full year 2013 guidance as a result. After recognizing significant profits, we trimmed our position in the stock earlier this year because of concerns about the impact that increased focus on cost containment in the healthcare system might have on the company's long- term growth prospects. We continue to own a small position in the Fund.
From Ron Baron's Baron Funds third quarter 2013 report.
From Ron Baron's Baron Funds third quarter 2013 report.
